Tag: Medical marijuana
-
![Canntab Therapeutics (PILL.C): The Canadian weed sector is struggling, but new consumer products have room to scale]()
Canntab Therapeutics (PILL.C): The Canadian weed sector is struggling, but new consumer products have room to scale
If we’re honest about it – if we’re REALLY honest about it – Canada has fumbled its advantage in the cannabis sector. First to market, first to raise hundreds of millions in financing, first to legalize, first to recreationalize (not a word but I’m on a roll), and it’s all really been for naught. In…
-
![Heritage Cannabis (CANN.C) launches new consumer product as global cannabis stocks rally 61% in Q4, 2020]()
Heritage Cannabis (CANN.C) launches new consumer product as global cannabis stocks rally 61% in Q4, 2020
CANN focuses on extraction and the creation of derivative products for recreational and medical consumers.
-
![Heritage Cannabis (CANN.C) granted oil sales licence – CannaCure’s Fort Erie facility in focus]()
Heritage Cannabis (CANN.C) granted oil sales licence – CannaCure’s Fort Erie facility in focus
CannaCure’s goal is “to transform the global marijuana landscape through innovative growth strategies and strategic partnerships with manufacturers of cannabis products.”
-
Heritage Cannabis (CANN.C) is so close profitability, it’s breaking social distancing rules
Sharples believes that Purefarma, Pura Vida, new contract manufacturing agreements, expansion of Canadian territories, the edibles product launch and the acquisition of Opticann expanding CANN’s U.S. presence will accelerate revenue going forward.
-
Heritage Cannabis (CANN.C) to develop vape oil with Sugarbud’s biomass
Heritage is positioning itself to radically expand its sales territory.
-
Heritage Cannabis (CANN.C) acquires Opticann – to create an international medical footprint
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”.
-
![Experion (EXP.V) CEO Jay Garnett lays out a stunningly simple master plan]()
Experion (EXP.V) CEO Jay Garnett lays out a stunningly simple master plan
A scrappy pioneer industry like cannabis attracts CEOs with diverse backgrounds. Before becoming a weed titan, Bruce Linton, the CEO of Canopy Growth (WEED.T) was an IT executive. Adam Bierman, the CEO of MedMen (MMEN.C) was a health & wellness marketer. Brendan Kennedy, the CEO of Tilray (TLRY.Q) was the COO of an analytics co.…
-
![Heritage Cannabis (CANN.C) acquires a 30% stake in EndoCanna]()
Heritage Cannabis (CANN.C) acquires a 30% stake in EndoCanna
Heritage Cannabis (CANN.C) is back in the headlines Wednesday after announcing plans to acquire a minority stake in EndoCanna, one of California’s leading DNA-testing marijuana companies. The news comes about a week after Equity Guru identified extracts and their derivatives as one of the final frontiers of the cannabis boom – in an article covering…
-
Turning it around: The lesson Lifestyle Delivery Systems (LDS.C) has for MedMen (MMEN.C)
To say there have been angry phone calls these past few days would be an understatement. Folks who helped take MedMen Enterprises Inc. Class B Subordinate Voting Shares (MMEN.C) (hey, that’s the CSE’s label, not mine) to the public markets and were looking at making a great amount of cash doing so, aren’t so pleased that our…
-
Green Organic Dutchman (TGOD.T) & MedMen (MMEN.C) have big days, but only one is smiling
The Green Organic Dutchman (TGOD.T) is nearing being a billion dollar company, after its stock ran up 13.9% today on news that it would license soluble cannabinoid tech from Stillwater Foods. The Green Organic Dutchman Holdings Ltd. has entered into an exclusive agreement with Stillwater Brands to license Ripple SC (soluble cannabinoids) ingredient technology, and…
